Patient Centered Clinical Decision Support for Hereditary Cancer Syndromes

NAEnrolling by invitationINTERVENTIONAL
Enrollment

2,488

Participants

Timeline

Start Date

July 9, 2025

Primary Completion Date

June 30, 2028

Study Completion Date

March 31, 2029

Conditions
Hereditary Breast/Ovarian Cancer (brca1, brca2)Lynch SyndromeGenetic VariationHBOC SyndromeHereditary Cancer Syndromes
Interventions
OTHER

Patient Centered Clinical Decision Support (PC-CDS)

The intervention provides patient specific recommendations on managing cancer risk due to hereditary cancer gene variants that is integrated into an existing point of care clinical decision support system that algorithmically identifies study-eligible patients and deploys patient-specific CDS output at an index visit and all subsequent primary care encounters using the most up to date available clinical information.

Trial Locations (1)

55440

HealthPartners Medical Group, Minneapolis

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

HealthPartners Institute

OTHER